Cialis ® (tadalafil) tablets

2.5 mg, 5 mg, 10mg, 20 mg tablets

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

CIALIS® (tadalafil): Increased Risk of Sudden Hearing Loss With Once Daily Use

There is no evidence to suggest once-a-day dosing of tadalafil increases the risk of sudden hearing loss compared with as-needed use of a PDE5 inhibitor.

Detailed Information

Sudden hearing loss has been reported in men taking PDE5 inhibitors, including tadalafil. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors.1

We have no evidence to suggest that once-a-day dosing of tadalafil increases the risk of sudden hearing loss compared with as-needed use of a PDE5 inhibitor.

Physicians should advise patients to stop taking PDE5 inhibitors, including tadalafil, and seek prompt medical attention in the event of sudden decrease or loss of hearing.1

Enclosed Prescribing Information

CIALIS® (tadalafil) tablets, for oral use, Lilly

Reference

1. Cialis [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.

Glossary

PDE5 = phosphodiesterase type 5

Date of Last Review: October 08, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical